RAPT Therapeutics Announces Management Promotions
Retrieved on:
Wednesday, March 4, 2020
Both Paul and Lisa continue to make incredible contributions to RAPTs success in setting and implementing strategic business and scientific plans, said Brian Wong, M.D., Ph.D., President and CEO of RAPT Therapeutics.
Key Points:
- Both Paul and Lisa continue to make incredible contributions to RAPTs success in setting and implementing strategic business and scientific plans, said Brian Wong, M.D., Ph.D., President and CEO of RAPT Therapeutics.
- Paul joined RAPT Therapeutics in 2016, as Vice President of Quantitative and Computational Biology.
- Lisa joined RAPT Therapeutics in 2018, as Senior Director of Business Development and Strategy.
- Prior to joining RAPT, she served as Director of Alliance Management for Nurix, Inc. where she managed drug discovery and development strategic alliances with pharma partners in addition to management of strategic research collaborations.